Top Glove sees demand doubling when vaccines ready by year-end


Its chairman Tan Sri Lim Wee Chai said that over the long term, the glove business remained good and healthy, with the company's share price depending on the earnings and performance.

KUALA LUMPUR: While pharmaceutical companies are gaining momentum on positive COVID-19 vaccination news, Top Glove Corporation Bhd expects demand for examination gloves to double when the vaccines are ready by year-end.

Its chairman Tan Sri Lim Wee Chai said that over the long term, the glove business remained good and healthy, with the company's share price depending on the earnings and performance.

The Star 6.6 DEAL: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Top Glove , Demand , Covid-19 update , Lim Wee Chai

Next In Business News

Ringgit ends lower against the US$ as global uncertainties weigh on sentiment
MISC renews Menara Dayabumi lease with PETRONAS in RM433mil 15-year deal
Malaysia Airports allocates RM11bil capex for infrastructure expansion over five years
IOIPG to return to FBM KLCI, Sime Darby on reserve list
Sentoria shares to be suspended from June 12, faces delisting
AirAsia's outstanding bill settled, says CAAP
Tycoon Vincent Tan cuts Berjaya stake in asset sales
Pentech's IPO oversubscribed 120.98 times
Sapura Industrial to dispose of Melaka land for RM10.48mil
Stocks struggle after Broadcom dive; oil eases off highs

Others Also Read